Working Together to Diagnose Idiopathic Pulmonary Fibrosis

Idiopathic Pulmonary Fibrosis (IPF)

Impact of IPF

Consequences of Missing a Diagnosis of IPF

Early Diagnosis of IPF Is Important to Improve Long-Term Treatment Outcomes

Early Diagnosis of IPF – Expert Perspective

Diagnosis of IPF: Start With Excluding Other Forms of ILD

Diagnosis of IPF: Key Assessments

IPF Diagnosis: HRCT as a 'Gatekeeper' in Initial Patient Evaluation

HRCT Patterns and the Diagnosis of IPF: UIP and Probable UIP

HRCT Patterns and the Diagnosis of IPF: Indeterminate for UIP and Alternative Diagnosis

'Indeterminate for UIP' Remains a Challenge

Diagnosis of IPF: Guideline Updates (1 of 2)

Diagnosis of IPF: Guideline Updates (2 of 2)

When Is Histopathology Necessary?

Selection of Patients in Need of a Surgical Lung Biopsy Is Key

Transbronchial Lung Cryobiopsy

BAL in Patients Suspected to Have IPF -- Expert Perspective

Histopathology Patterns for IPF Diagnosis

Diagnosis Based on HRCT and Histopathology Patterns

Diagnostic Algorithm for IPF

Key Challenges in the Diagnosis of IPF -- Expert Perspective

Diagnosis in Patients Who Should Have but Are Unable to Undergo Lung Biopsy

Misdiagnosis and Diagnostic Delay in Patients With ILD

Modest Interobserver Agreement in UIP Diagnosis Categories by HRCT, Regardless of Experience Level

MDD for the Diagnosis of Patients With IPF

Agreement Among MDD Teams Is Good and (Non-Significantly) Better than Agreement Among Individual Specialties

Key Points to Communicate to Patients Diagnosed With IPF

Concluding Remarks

Abbreviations